NCT07371923
- Conditions
- Diffuse Large B Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Beijing Tongren Hospital Beijing, Beijing Municipality, China
Clinical trial condition
Lymphoma, Large B-Cell, Diffuse
Explore clinical trials studying Lymphoma, Large B-Cell, Diffuse. Study availability and eligibility vary by location and protocol.
1,264 public trials
216 recruiting studies
Lymphoma, Large B-Cell, Diffuse trial results
NCT07368270
- Conditions
- Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Suzhou Hongci Hematology Hospital Suzhou, China
NCT06834373
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +39 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Mayo Clinic in Florida Jacksonville, Florida, United States
- Mayo Clinic Health System in Albert Lea Albert Lea, Minnesota, United States
- Mayo Clinic Health Systems-Mankato Mankato, Minnesota, United States
NCT06846463
- Conditions
- DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Diffuse Large B-cell Lymphoma, +13 more
- Locations
-
- Virginia Commonwealth University Richmond, Virginia, United States
NCT06693830
- Conditions
- Diffuse Large B Cell Lymphoma, Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Hemic and Lymphatic Diseases, +15 more
- Locations
-
- Columbia University New York, United States
Recruiting
Relmacabtagene Autoleucel Combined With Sintilimab for Relapsed/Refractory B-cell Lymphoma
NCT07077512
- Conditions
- Follicular Lymphoma ( FL), Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
- Locations
-
- Sun Yat-sen Universitiy Cancer Center Guangzhou, China
- Fifth Affiliated Hospital of Guangzhou Medical University Guangzhou, China
- Guangzhou overseas Chinese hospital Guangzhou, China
NCT06588205
- Conditions
- Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements, +11 more
- Locations
-
- A.O.U. SS. Antonio e Biagio e C. Arrigo - S.C.D.U. Ematologia Alessandria, Italy
- A.O.U. Ospedali Riuniti delle Marche - Clinica di Ematologia Ancona, Italy
- I.R.C.C.S. Istituto Tumori Giovanni Paolo II - U.O.C. Ematologia Bari, Italy
- ASST Spedali Civili - S.C. Ematologia Brescia, Italy
NCT06022029
- Conditions
- Bites and Stings, Bladder Cancer, Breast Diseases, +72 more
- Locations
-
- California Research Institute Los Angeles, California, United States
- BRCR Global Tamarac, Florida, United States
- Gabrail Cancer Center Research Canton, Ohio, United States
- Ohio State University Columbus, Ohio, United States
NCT06736613
- Conditions
- DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Diffuse Large B Cell Lymphoma, +21 more
- Locations
-
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
- Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) Commack, New York, United States
NCT07062627
- Conditions
- Diffuse Large B Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
- Locations
-
- Asan Medical Center Seoul, South Korea